Save your place

Sign in to WhoBought

Please try again later.

Pyxis Oncology, Inc. (PYXS) institutional ownership

Latest close $2.23 Jul 21, 2026
Market cap$68M 52-week range SectorHealthcare
Funds holding · Q1 2026
72
reported PYXS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
23 buyers · 49 sellers

Pyxis Oncology, Inc. (PYXS) price and institutional activity

Dates

Q1 2026

$0 bought by 23 investors
Jacobs Levy Equity Management, IncLaurion Capital Management LP +21 more
$0 sold by 49 investors
Bank of America CorpJane Street Group, LLC +47 more
Bought Sold Totals per quarter; hover a bar for the names.

Pyxis Oncology, Inc. (PYXS) institutional activity · 72

Investor Type Est. change Change Δ Own Date
Bank of America Corp · Reduced
Change −571K Date Q1 2026
Bank of America Corp Reduced· Q1 2026 −571K Q1 2026
Jane Street Group, LLC · Reduced
Change −482K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −482K Q1 2026
Jacobs Levy Equity Management, Inc · New
Change +461K Date Q1 2026
Jacobs Levy Equity Management, Inc New· Q1 2026 +461K Q1 2026
Atle Fund Management AB · Reduced
Change −420K Date Q1 2026
Atle Fund Management AB Reduced· Q1 2026 −420K Q1 2026
Millennium Management LLC · Reduced
Change −345K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −345K Q1 2026
Exoduspoint Capital Management, LP · Exited
Change −318K Δ Own −100.0% Date Q1 2026
Exoduspoint Capital Management, LP Exited· Q1 2026 −318K −100.0% Q1 2026
Laurion Capital Management LP · Added
Change +201K Date Q1 2026
Laurion Capital Management LP Added· Q1 2026 +201K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −182K −74.9% Q1 2026
Graham Capital Management, L.P. · Reduced
Change −161K Date Q1 2026
Graham Capital Management, L.P. Reduced· Q1 2026 −161K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +160K +22.0% Q1 2026
Point72 Asset Management, L.P. · Reduced
Change −156K Δ Own −83.0% Date Q1 2026
Point72 Asset Management, L.P. Reduced· Q1 2026 −156K −83.0% Q1 2026
Acadian Asset Management LLC · New
Change +144K Date Q1 2026
Acadian Asset Management LLC New· Q1 2026 +144K Q1 2026
UBS Group AG · Reduced
Change −139K Date Q1 2026
UBS Group AG Reduced· Q1 2026 −139K Q1 2026
Qube Research & Technologies Ltd · Reduced
Change −135K Date Q1 2026
Qube Research & Technologies Ltd Reduced· Q1 2026 −135K Q1 2026
Quadrature Capital Ltd · Exited
Change −101K Δ Own −100.0% Date Q1 2026
Quadrature Capital Ltd Exited· Q1 2026 −101K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 72

Famous investor activity in Pyxis Oncology, Inc. (PYXS)

Pyxis Oncology, Inc. (PYXS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Dupont Jakob · Director Sell −$107K
Price $3.06 Qty −35K Owned 39K ΔOwn −47.5% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Dupont Jakob Director Sell $3.06 −35K −$107K 39K −47.5% Jun 30, 2026 Jul 2, 2026
Dupont Jakob · Director 2 operations 0
Price $1.60 Owned 357K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Dupont Jakob Director 2 operations $1.60 0 357K Jun 30, 2026 Jul 2, 2026
Dupont Jakob · Director Grant (A) 46K
Owned 46K Trade date Mar 24, 2026 Filed date Mar 25, 2026
Dupont Jakob Director Grant (A) 46K 46K Mar 24, 2026 Mar 25, 2026
Wadhane Jitendra · Officer 2 operations 372K
Owned 263K Trade date Mar 24, 2026 Filed date Mar 25, 2026
Wadhane Jitendra Officer 2 operations 372K 263K Mar 24, 2026 Mar 25, 2026
Flavin John L. · Director Grant (A) 46K
Owned 46K Trade date Mar 24, 2026 Filed date Mar 25, 2026
Flavin John L. Director Grant (A) 46K 46K Mar 24, 2026 Mar 25, 2026
Metzger Michael A. · Director Grant (A) 46K
Owned 46K Trade date Mar 24, 2026 Filed date Mar 25, 2026
Metzger Michael A. Director Grant (A) 46K 46K Mar 24, 2026 Mar 25, 2026
Lewis-Hall Freda C. · Director Grant (A) 46K
Owned 46K Trade date Mar 24, 2026 Filed date Mar 25, 2026
Lewis-Hall Freda C. Director Grant (A) 46K 46K Mar 24, 2026 Mar 25, 2026
Cline Darren S. · Director Grant (A) 46K
Owned 46K Trade date Mar 24, 2026 Filed date Mar 25, 2026
Cline Darren S. Director Grant (A) 46K 46K Mar 24, 2026 Mar 25, 2026
Humphrey Rachel · Director Grant (A) 46K
Owned 46K Trade date Mar 24, 2026 Filed date Mar 25, 2026
Humphrey Rachel Director Grant (A) 46K 46K Mar 24, 2026 Mar 25, 2026
Palani Santhosh · Director Grant (A) 46K
Owned 46K Trade date Mar 24, 2026 Filed date Mar 25, 2026
Palani Santhosh Director Grant (A) 46K 46K Mar 24, 2026 Mar 25, 2026
Civik Thomas · Director, Officer Grant (A) 690K
Owned 690K Trade date Feb 3, 2026 Filed date Feb 5, 2026
Civik Thomas Director, Officer Grant (A) 690K 690K Feb 3, 2026 Feb 5, 2026
11 of 11

Pyxis Oncology, Inc. (PYXS) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Gordonmd Global Investments LP 10.0M
% of shares outstanding 12.1% Filing date Jul 2, 2026
Gordonmd Global Investments LP 10.0M 12.1% Jul 2, 2026
Sullivan Lara 5.5M
% of shares outstanding 8.9% Filing date Apr 3, 2024
Sullivan Lara 5.5M 8.9% Apr 3, 2024
Laurion Capital Management LP 4.8M
% of shares outstanding 7.7% Filing date Feb 9, 2026
Laurion Capital Management LP 4.8M 7.7% Feb 9, 2026
Millennium Management LLC 3.5M
% of shares outstanding 5.7% Filing date Jul 1, 2025
Millennium Management LLC 3.5M 5.7% Jul 1, 2025
Biotechnology Value Fund L P 4.6M
% of shares outstanding 5.5% Filing date Jul 10, 2026
Biotechnology Value Fund L P 4.6M 5.5% Jul 10, 2026
Bayer World Investments B.V. 2.7M
% of shares outstanding 4.7% Filing date Nov 6, 2024
Bayer World Investments B.V. 2.7M 4.7% Nov 6, 2024
Integrated Core Strategies (us) LLC 2.5M
% of shares outstanding 4.0% Filing date May 6, 2025
Integrated Core Strategies (us) LLC 2.5M 4.0% May 6, 2025
Pfizer Inc 7.0M
% of shares outstanding 2.9% Filing date Mar 23, 2023
Pfizer Inc 7.0M 2.9% Mar 23, 2023
8 of 11

Pyxis Oncology, Inc. (PYXS) ownership FAQ

Who owns PYXS?

72 reporting institutions disclosed PYXS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.